Listar por autor "Pérez Sanz, Jairo"
Mostrando ítems 1-4 de 4
-
Circulating low density neutrophils are associated with resistance to anti-PD1 immunotherapy in squamous head and neck cancer
Arrazubi, Virginia; Goñi Irigoyen, Saioa ; González Borja, Iranzu; Hernández García, Irene; Arasanz Esteban, Hugo; Pérez Sanz, Jairo; Bocanegra Gondán, Ana Isabel; Kochan, Grazyna; Escors Murugarren, David; Ruiz de Azúa, Yerani; Elizalde, Jesús María; Viúdez, Antonio; Vera García, Ruth (Wiley, 2023) Artículo / ArtikuluaBackground: Identification of predictive biomarkers to Immune checkpoint inhibitors (ICIs) in head and neck cancer (HNSCC) is an unmet need. Methods: This was a prospective observational study including 25 patients with ... -
Cytokines and lymphoid populations as potential biomarkers in locally and borderline pancreatic adenocarcinoma
González Borja, Iranzu; Viúdez, Antonio; Alors-Pérez, Emilia; Goñi Irigoyen, Saioa ; Amat Villegas, Irene ; Ghanem, Ismael; Pazo-Cid, Roberto; Feliu, Jaime; Alonso, Laura; López López, Carlos; Arrazubi, Virginia; Gallego, Javier; Pérez Sanz, Jairo; Hernández García, Irene; Vera García, Ruth; Castaño, Justo P.; Fernández Irigoyen, Joaquín (MDPI, 2022) Artículo / ArtikuluaDespite its relative low incidence, PDAC is one of the most aggressive and lethal types of cancer, being currently the seventh leading cause of cancer death worldwide, with a 5-year survival rate of 10.8%. Taking into ... -
Deciphering CHFR role in pancreatic ductal adenocarcinoma
González Borja, Iranzu; Alors-Pérez, Emilia; Amat Villegas, Irene ; Alonso, Laura; Viyuela-García, Cristina; Goñi Irigoyen, Saioa ; Reyes, José C.; Ceballos-Chávez, María; Hernández García, Irene; Sánchez-Frías, Marina E.; Santamaría, Enrique; Razquin, Socorro; Arjona Sánchez, Álvaro; Arrazubi, Virginia; Pérez Sanz, Jairo; Vera García, Ruth; Fernández Irigoyen, Joaquín ; Castaño, Justo P.; Viúdez, Antonio (Frontiers Media, 2021) Artículo / ArtikuluaCheckpoint with forkhead-associated and ring finger domains (CHFR) has been proposed as a predictive and prognosis biomarker for different tumor types, but its role in pancreatic ductal adenocarcinoma (PDAC) remains unknown. ... -
Omics approaches in pancreatic adenocarcinoma
González Borja, Iranzu; Viúdez, Antonio; Goñi Irigoyen, Saioa ; Santamaría, Enrique; Carrasco García, Estefanía; Pérez Sanz, Jairo; Hernández García, Irene (MDPI, 2019) Artículo / ArtikuluaPancreatic ductal adenocarcinoma, which represents 80% of pancreatic cancers, is mainly diagnosed when treatment with curative intent is not possible. Consequently, the overall five-year survival rate is extremely dismal—around ...